Logo image of BOI.PA

BOIRON SA (BOI.PA) Stock Price, Forecast & Analysis

Europe - Euronext Paris - EPA:BOI - FR0000061129 - Common Stock

30.35 EUR
-0.3 (-0.98%)
Last: 1/23/2026, 7:00:00 PM

BOI.PA Key Statistics, Chart & Performance

Key Statistics
Market Cap532.64M
Revenue(TTM)504.86M
Net Income(TTM)19.37M
Shares17.55M
Float3.50M
52 Week High32.25
52 Week Low20.85
Yearly Dividend1.35
Dividend Yield3.97%
EPS(TTM)1.12
PE27.1
Fwd PE13.12
Earnings (Next)N/A
IPO1991-03-25
Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
BOI.PA short term performance overview.The bars show the price performance of BOI.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

BOI.PA long term performance overview.The bars show the price performance of BOI.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 10 -10 -20

The current stock price of BOI.PA is 30.35 EUR. In the past month the price increased by 0.5%. In the past year, price increased by 19.25%.

BOIRON SA / BOI Daily stock chart

BOI.PA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to BOI.PA. When comparing the yearly performance of all stocks, BOI.PA is one of the better performing stocks in the market, outperforming 76.78% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BOI.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to BOI.PA. BOI.PA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BOI.PA Financial Highlights

Over the last trailing twelve months BOI.PA reported a non-GAAP Earnings per Share(EPS) of 1.12. The EPS decreased by -18.09% compared to the year before.


Industry RankSector Rank
PM (TTM) 3.84%
ROA 3.45%
ROE 5.25%
Debt/Equity 0.04
Chartmill High Growth Momentum
EPS Q2Q%241.06%
Sales Q2Q%7.58%
EPS 1Y (TTM)-18.09%
Revenue 1Y (TTM)4.8%

BOI.PA Forecast & Estimates

For the next year, analysts expect an EPS growth of 5.53% and a revenue growth 2.95% for BOI.PA


Analysts
Analysts80
Price TargetN/A
EPS Next Y5.53%
Revenue Next Year2.95%

BOI.PA Ownership

Ownership
Inst Owners5.63%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

About BOI.PA

Company Profile

BOI logo image Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,736 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.

Company Info

BOIRON SA

2 avenue de l ouest Lyonnais

Rontalon AUVERGNE-RHONE-ALPES FR

Employees: 2788

BOI Company Website

BOI Investor Relations

Phone: 33478456100

BOIRON SA / BOI.PA FAQ

Can you describe the business of BOIRON SA?

Boiron SA engages in the manufacturing and selling homeopathic medicines. The company is headquartered in Rontalon, Auvergne-Rhone-Alpes and currently employs 2,736 full-time employees. The firm develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. The company also produces medicines based on trace elements, phytotherapy remedies, food supplements, as well as health and beauty care products. In addition, the Company owns a research center, which works for the development of homeopathy within the world of medicine. Boiron SA operates through a number of subsidiaries, which are based in Italy, Spain, Belgium, the Czech Republic, Slovakia, Russia, Romania, Poland, Hungary, the United States, Canada and Brazil, among others.


What is the stock price of BOIRON SA today?

The current stock price of BOI.PA is 30.35 EUR. The price decreased by -0.98% in the last trading session.


Does BOIRON SA pay dividends?

BOIRON SA (BOI.PA) has a dividend yield of 3.97%. The yearly dividend amount is currently 1.35.


What is the ChartMill rating of BOIRON SA stock?

BOI.PA has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


On which exchange is BOI.PA stock listed?

BOI.PA stock is listed on the Euronext Paris exchange.


What is the Price/Earnings (PE) ratio of BOIRON SA (BOI.PA)?

The PE ratio for BOIRON SA (BOI.PA) is 27.1. This is based on the reported non-GAAP earnings per share of 1.12 and the current share price of 30.35 EUR.


Can you provide the ownership details for BOI stock?

You can find the ownership structure of BOIRON SA (BOI.PA) on the Ownership tab.